The US Food and Drug Administration has approved Journavx, also known as suzetrigine 50 milligram oral tablets—a first-in-class non-opioid analgesic—to treat moderate to severe acute pain in adults.

The De-Stress Lounge is a next-generation massage chair that offers deep tissue massage, heat therapy, and zero-gravity ...

WHEN you’re unwell, all you want to do is collapse into bed. To aid your recovery, there are some sleep positions that are better than others for easing symptoms, experts say. Lisa Artis, ...

The U.S. Food and Drug Administration (FDA) has approved a new drug for the treatment of moderate-to-severe pain that is a non-opioid and carries less risks of addiction than opioids.

Other research has shown red light therapy could minimize the appearance of wrinkles, hyperpigmentation, and broken blood ...

( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...